News

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...